Viewing Study NCT06682806

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-26 @ 2:39 PM
Ignite Modification Date: 2026-03-01 @ 5:00 PM
Study NCT ID: NCT06682806
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-08-28
First Post: 2024-10-29
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study of PRT3789 in Combination With Pembrolizumab in Patients With Advanced or Metastatic Solid Tumors With a SMARCA4 Mutation
Sponsor: Prelude Therapeutics
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Solid Tumor View
None Esophageal Cancer View
None Metastatic Solid Tumor View
None Non-small Cell Lung Cancers View
None SMARCA4 Gene Mutation View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Advanced Solid Tumors View
None BRG1 View
None BRM View
None Esophageal Cancer View
None Metastatic Solid Tumors View
None Non-Small Cell Lung Cancers View
None NSCLC View
None PRT3789 View
None Pembrolizumab View
None Keytruda® View
None SMARCA2 Degrader View
None SMARCA4 View